Theophylline: Potential antiinflammatory effects in nocturnal asthma

Journal of Allergy and Clinical Immunology

Volumn 97, Issue 6, 1996, Pages 1242-1246

  Kraft, Monica ^b   Torvik, Julie A ^b   Trudeau, John B ^b   Wenzel, Sally E ^b   Martin, Richard J ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b NONE

Author keywords

asthma; inflammation; lung function; nocturnal; Theophylline

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; ATROPINE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIMYCIN; CODEINE; LEUKOTRIENE B4; MIDAZOLAM; PROSTAGLANDIN SYNTHASE; TERBUTALINE; THEOPHYLLINE; THROMBOXANE B2;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BRONCHOSCOPY; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG FUNCTION; LUNG LAVAGE; MALE; NIGHT; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFLAMMATION; SPIROMETRY; TABLET; THEOPHYLLINE BLOOD LEVEL;

EID: 0029941523     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(96)70191-4     Document Type: Article

References (13)

1. Sullivan P, Bekir S, Jaffar Z, Page C, Jeffer P, Costello J. Antiinflammatory effects of low-dose oral theophylline in atopic asthma. Lancet 1994;343:1006-8.
2. Kidney J, Dominguez M, Taylor P, et al. Immunomodulation by theophylline in asthma: demonstration by withdrawal therapy. Am J Respir Crit Care Med 1995;151:1907-14.
3. Pauwels R. New aspects of the therapeutic potential of theophylline. J Allergy Clin Immunol 1989;83:548-53.
4. Dent G, Giembycz M, Rabe K, Wolf B, Barnes P, Magnussen H. Theophylline suppresses human macrophage respiratory burst through phosphodiesterase inhibition. Am J Respir Cell Mol Biol 1994;10:565-72.
5. Naclerio R, Bartenfelder D, Proud D, et al. Theophylline reduces histamine release during pollen-induced rhinitis. J Allergy Clin Immunol 1986;78:874-6.
6. Calhoun W, Bates M, Schrader L, Sedgwick J, Busse W. Characteristics of peripheral blood eosinophils in patients with nocturnal asthma. Am Rev Respir Dis 1992;145:577-81.
7. Jarjour N, Calhoun W, Busse W. Enhanced metabolism of oxygen radicals in nocturnal asthma. Am Rev Respir Dis 1992;146:905-11.
8. Martin R, Cicutto L, Smith H, Ballard R, Szefler S. Airways inflammation in nocturnal asthma. Am Rev Respir Dis 1991;143:351-7.
9. 1. J Allergy Clin Immunol 1994;94:870-81.
10. Willcox M, Kervitsky A, Wetters L, King T. Quantification of cells recovered by bronchoalveolar lavage. Am Rev Respir Dis 1988;138:74-80.
11. Cohen J. A t test for means. In: Cohen J, ed. Statistical power analysis for the behavior sciences. Hillsdale: L. Erlbaum Associates, 1989:19-74.
12. Jones B, Kenward M, eds. Design and analysis of crossover trials. New York: Chapman and Hall, 1989.
13. D'Alonzo G, Smolensky M, Feldman S, et al. Twenty-four hour lung function in adult patients with asthma. Am Rev Respir Dis 1990;142:84-90.